Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(24 sites)
United States
University of California Los Angeles (UCLA) School of Medicine, Los Angeles, California University of Florida (UF) Health Shands Hospital, Gainesville, Florida Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois Oregon Health and Science University, Portland, Oregon University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania Vanderbilt University Medical Center, Nashville, Tennessee University of Texas Southwestern, Dallas, Texas University of Texas Health (UTHealth) Science Center at Houston, Houston, Texas Utah Health - The University of Utah Hospital, Salt Lake City, Utah Australia
Royal Adelaide Hospital, Adelaide Royal Melbourne Hospital, Parkville Mater Health - Mater Hospital Brisbane, South Brisbane Canada
M.A.G.I.C Clinic, Calgary, Alberta Czechia
Fakultní nemocnice Královské Vinohrady, Prague France
Centre Hospitalier Régional Universitaire (CHRU) de Tours - Hôpital Bretonneau, Tours Germany
Universitätsklinikum Münster, Münster Japan
Nihon University Hospital, Chiyoda-ku Fujita Health University, Kutsukake-cho Osaka Metropolitan University Hospital, Osaka Netherlands
Universitair Medisch Centra (AMC)- Amsterdam, Amsterdam Beatrix Children's Hospital, Groningen Poland
Pomorski Uniwersytet Medyczny w Szczecinie, Szczecin Spain
Hospital Universitario Ramón y Cajal, Madrid Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela